American College of Cardiology

Coverage of the latest and most clinically impactful data from the American College of Cardiology's 71st Scientific Sessions. Taking place in-person in Washington D.C. with a virtual experience available online, ACC.22 is scheduled to be held from April 2-4 and feature more than 3000 abstracts and more than 80 live streaming sessions. Coverage of the event will include articles on late-breaking data, video interviews with leading experts, and more.

Complete Revascularization Reduces Both Event Risk and Angina Burden in STEMI

April 06, 2022

Deepak Bhatt, MD, MPH, discusses the results of a prespecified analysis of the COMPLETE detailing a complete revascularization approach to PCI in STEMI resulted in less angina burden than a culprit-lesion-only approach at 3 years.

Don't Miss a Beat: ACC.22 Recap of DIAMOND, SODIUM-HF, and PROMPT-HF

April 05, 2022

Don't Miss a Beat hosts Drs. Vaduganathan and Greene provide insight into the results of trials from ACC.22 late-breaking sessions they highlighted in the preview episode they recorded ahead of the American College of Cardiology's 71st Annual Scientific Session.

Sotagliflozin Reduces Stroke, MI, and CV Death, Regardless of CVD History

April 04, 2022

Deepak Bhatt, MD, MPH, breaks down data from the SCORED trial presented at ACC.22, which demonstrated sotagliflozin provided significant benefit in terms of reducing total MACE, total MI, and total stroke, regardless of whether a patient had a history of cardiovascular disease.